$CRDL – Get ready for the biggest catalyst soon. The company may release FDA decision for Pericarditis Ph2 trial! It may hit the market next week.
Considering the rise of 180% this year, the stock looks good and if we get positive outcome, the stock may be ready to fly big. Analysts are already very bullish on the stock with PT of $8. So biotech traders must keep $CRDL on their radar.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.